Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anke Reinacher-Schick

Showing results (1-10 of 120) with videos related to

Pageof 12
Sort By:
Deutsches Arzteblatt International|March 1, 2024
In ReplyAnke Reinacher-Schick
Zeitschrift Fur Gastroenterologie|November 18, 2008
[Controversies in gastrointestinal oncology]Anke Reinacher-Schick
Zeitschrift Fur Gastroenterologie|June 17, 2020
Anke Reinacher-Schick, A Tannapfel
Visceral Medicine|July 18, 2019
Immunotherapy in Gastrointestinal Cancer: Where Do We Stand?Andrea Tannapfel, Anke Reinacher-Schick
Onkologie|December 17, 2008
[Colorectal carcinoma--molecular markers in clinical routine]Andrea Tannapfel, Anke Reinacher-Schick
Viszeralmedizin|August 20, 2015
Colorectal Adenoma - Resection Techniques and SurveillanceGeorg Kähler, Anke Reinacher-Schick
Nature Clinical Practice. Gastroenterology & Hepatology|April 3, 2008
Drug insight: antiangiogenic therapies for gastrointestinal cancers--focus on monoclonal antibodiesAnke Reinacher-Schick, Michael Pohl, Wolff Schmiegel
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|August 13, 2021
[Modern concepts of systemic treatment for adjuvant and palliative treatment of locally advanced or metastasized esophageal cancer]Sylvie Lorenzen, Anke Reinacher-Schick, Michael Masetti
Journal of Evaluation in Clinical Practice|October 28, 2017
What does physicians' clinical expertise contribute to oncologic decision-making? A qualitative interview studySabine Salloch, Ina Otte, Anke Reinacher-Schick, et al.
Therapeutic Advances in Neurological Disorders|October 3, 2017
Bortezomib in severe MuSK-antibody positive myasthenia gravis: first clinical experienceChristiane Schneider-Gold, Anke Reinacher-Schick, Gisa Ellrichmann, et al.
Pageof 12

Showing results (1-10 of 120) with videos related to

Sort By:
Pageof 12
Deutsches Arzteblatt International|March 1, 2024
In ReplyAnke Reinacher-Schick
Zeitschrift Fur Gastroenterologie|November 18, 2008
[Controversies in gastrointestinal oncology]Anke Reinacher-Schick
Zeitschrift Fur Gastroenterologie|June 17, 2020
Anke Reinacher-Schick, A Tannapfel
Visceral Medicine|July 18, 2019
Immunotherapy in Gastrointestinal Cancer: Where Do We Stand?Andrea Tannapfel, Anke Reinacher-Schick
Onkologie|December 17, 2008
[Colorectal carcinoma--molecular markers in clinical routine]Andrea Tannapfel, Anke Reinacher-Schick
Viszeralmedizin|August 20, 2015
Colorectal Adenoma - Resection Techniques and SurveillanceGeorg Kähler, Anke Reinacher-Schick
Nature Clinical Practice. Gastroenterology & Hepatology|April 3, 2008
Drug insight: antiangiogenic therapies for gastrointestinal cancers--focus on monoclonal antibodiesAnke Reinacher-Schick, Michael Pohl, Wolff Schmiegel
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|August 13, 2021
[Modern concepts of systemic treatment for adjuvant and palliative treatment of locally advanced or metastasized esophageal cancer]Sylvie Lorenzen, Anke Reinacher-Schick, Michael Masetti
Journal of Evaluation in Clinical Practice|October 28, 2017
What does physicians' clinical expertise contribute to oncologic decision-making? A qualitative interview studySabine Salloch, Ina Otte, Anke Reinacher-Schick, et al.
Therapeutic Advances in Neurological Disorders|October 3, 2017
Bortezomib in severe MuSK-antibody positive myasthenia gravis: first clinical experienceChristiane Schneider-Gold, Anke Reinacher-Schick, Gisa Ellrichmann, et al.
Pageof 12